Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 46, 2024 - Issue 1
Submit an article Journal homepage
2,260
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Exploration and validation of signature genes and immune associations in septic cardiomyopathy

Zhengbo Zhaoa Department of Cardiology, Yubei District Hospital of TCM, Chongqing, ChinaView further author information
,
Xiaojing Wangb Department of Cardiology, Jiulongpo District People’s Hospital, Chongqing, ChinaView further author information
,
Fangyan Tanc Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information
,
Han Liub Department of Cardiology, Jiulongpo District People’s Hospital, Chongqing, ChinaView further author information
,
Wan Chenb Department of Cardiology, Jiulongpo District People’s Hospital, Chongqing, ChinaView further author information
,
Jing Wangc Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information
,
Songbai Dengc Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaCorrespondence[email protected]
View further author information
&
Jianlin Duc Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2302570 | Received 11 Jul 2023, Accepted 15 Dec 2023, Published online: 27 Jan 2024

References

  • Lin YM, Lee MC, Toh HS, Chang WT, Chen SY, Kuo FH, Tang HJ, Hua YM, Wei D, Melgarejo J, et al. Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis. Ann Intensive Care. 2022;12(1):112. doi:10.1186/s13613-022-01089-3.
  • Carbone F, Liberale L, Preda A, Schindler TH, Montecucco F. Septic cardiomyopathy: from pathophysiology to the clinical setting. Cells. 2022;11(18):2833. doi:10.3390/cells11182833.
  • Zhang R, Di C, Gao H, Zhu Y, Li C, Zhu Z, Wang Q, Wang J, Zhou F, Wang S. Identification of iron metabolism-related genes in the circulation and myocardium of patients with sepsis via applied bioinformatics analysis. Front Cardiovasc Med. 2023;10:1018422. doi:10.3389/fcvm.2023.1018422.
  • Ma D, Qin X, Zhong ZA, Liao H, Chen P, Zhang B. Systematic analysis of myocardial immune progression in septic cardiomyopathy: immune-related mechanisms in septic cardiomyopathy. Front Cardiovasc Med. 2022;9:1036928. doi:10.3389/fcvm.2022.1036928.
  • Shi S, Pan X, Feng H, Zhang S, Shi S, Lin W. Identification of transcriptomics biomarkers for the early prediction of the prognosis of septic shock from pneumopathies. BMC Infect Dis. 2021;21(1):1190. doi:10.1186/s12879-021-06888-w.
  • Li J, Sun G, Ma H, Wu X, Li C, Ding P, Lu S, Li Y, Yang P, Li J, et al. Identification of immune-related hub genes and miRNA-mRNA pairs involved in immune infiltration in human septic cardiomyopathy by bioinformatics analysis. Front Cardiovasc Med. 2022;9:971543. doi:10.3389/fcvm.2022.971543.
  • Li J, Zhou L, Li Z, Yang S, Tang L, Gong H. Identification of crucial genes and infiltrating immune cells underlying sepsis-induced cardiomyopathy via weighted gene co-expression network analysis. Front Genet. 2021;12:812509. doi:10.3389/fgene.2021.812509.
  • Luo T, Yan H, Li X, Deng Y, Huang J, Li L, Xiao Z, Lu X. Proteomic analysis identified potential age-associated prognostic biomarkers in pneumonia-derived paediatric sepsis. Proteomics Clin Appl. 2022;16(3):e2100036. doi:10.1002/prca.202100036.
  • Sun J, Ge X, Wang Y, Niu L, Tang L, Pan S. USF2 knockdown downregulates THBS1 to inhibit the TGF-beta signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury. Pharmacol Res. 2022;176:105962. doi:10.1016/j.phrs.2021.105962.
  • Xie Y, Zhang J, Jin W, Tian R, Wang R. Role of Thrombospondin‑1 in sepsis‑induced myocardial injury. Mol Med Rep. 2021;24(6). doi:10.3892/mmr.2021.12509.
  • Jones TK, Reilly JP, Anderson BJ, Miano TA, Dunn TG, Weisman AR, Agyekum R, Feng R, Ittner CAG, Shashaty MGS, et al. Elevated plasma levels of matrix metalloproteinase-3 and tissue-inhibitor of matrix metalloproteinases-1 associate with organ dysfunction and mortality in sepsis. Shock. 2022;57(1):41–8. doi:10.1097/SHK.0000000000001833.
  • Hoffmann U, Brueckmann M, Borggrefe M. Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis? Crit Care. 2009;13(6):1006. doi:10.1186/cc8156.
  • Rai N, Khanna P, Kashyap S, Kashyap L, Anand RK, Kumar S. Comparison of serum nucleosomes and tissue inhibitor of metalloproteinase1 (TIMP1) in predicting mortality in adult critically ill patients in sepsis: prospective observational study. Indian J Crit Care Med. 2022;26(7):804–10. doi:10.5005/jp-journals-10071-24258.
  • Sharma C, Dobson GP, Davenport LM, Morris JL, Letson HL. The role of matrix metalloproteinase-9 and its inhibitor TIMP-1 in burn injury: a systematic review. Int J Burns Trauma. 2021;11(4):275–288.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.